We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$5.17B
AUM Growth
+$87.6M
Cap. Flow
-$368M
Cap. Flow %
-7.11%
Top 10 Hldgs %
64.49%
Holding
55
New
7
Increased
18
Reduced
19
Closed
9

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$304M
2
UHS icon
Universal Health Services
UHS
+$97.2M
3
CNC icon
Centene
CNC
+$94.9M
4
ALIT icon
Alight
ALIT
+$94.4M
5
CI icon
Cigna
CI
+$83.4M

Sector Composition

Rank Sector Weight
1 Healthcare 43.06%
2 Technology 16.29%
3 Industrials 12.23%
4 Materials 8.81%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTCH icon
26
Match Group
MTCH
$8.54B
$43.4M 0.84%
1,147,405
+793,183
+224% +$27.8M
TFX icon
27
Teleflex
TFX
$6.15B
$40.8M 0.79%
165,135
+42,653
+35% +$9.96M
GTM
28
ZoomInfo Technologies
GTM
$1.22B
$40.6M 0.79%
3,935,465
+2,367,542
+151% +$24.8M
MYGN icon
29
Myriad Genetics
MYGN
$304M
$34.6M 0.67%
1,261,530
-2,486,902
-66% -$67.3M
WDC icon
30
Western Digital
WDC
$156B
$29.7M 0.57%
+574,547
New +$29M
DD icon
31
DuPont de Nemours
DD
$19.5B
$24.5M 0.48%
+219,474
New +$22.4M
SEE
32
DELISTED
Sealed Air
SEE
$24.5M 0.47%
+674,656
New +$23.6M
BC icon
33
Brunswick
BC
$5.28B
$23.9M 0.46%
284,786
-140,848
-33% -$10.9M
EVLV icon
34
Evolv Technologies
EVLV
$1.07B
$19.8M 0.38%
4,892,358
-1,655,579
-25% -$5.78M
LYV icon
35
Live Nation Entertainment
LYV
$42.3B
$19.1M 0.37%
174,311
-59,585
-25% -$5.76M
BFLY icon
36
Butterfly Network
BFLY
$2.21B
$17.6M 0.34%
9,955,144
+1,921,643
+24% +$2.41M
BKD icon
37
Brookdale Senior Living
BKD
$3.43B
$17M 0.33%
2,500,000
-4,506,929
-64% -$32.2M
HSIC icon
38
Henry Schein
HSIC
$9.83B
$12.7M 0.25%
+174,662
New +$12.1M
LYFT icon
39
Lyft
LYFT
$6.19B
$10.1M 0.19%
789,394
-27,057
-3% -$323K
DMRC icon
40
Digimarc Corp
DMRC
$171M
$5.36M 0.1%
199,249
-92,606
-32% -$2.73M
DNA icon
41
Ginkgo Bioworks
DNA
$555M
$3.87M 0.07%
474,998
-187,502
-28% -$1.88M
HTZ icon
42
CALL
Hertz
HTZ
$638M
$1.65M 0.03%
+500,000
New +$1.75M
HTZ icon
43
Hertz
HTZ
$638M
$1.45M 0.03%
+439,246
New +$1.53M
OFIX icon
44
Orthofix Medical
OFIX
$428M
$987K 0.02%
63,196
-1,041,857
-94% -$16.7M
RPID icon
45
Rapid Micro Biosystems
RPID
$104M
$488K 0.01%
547,990
-652,798
-54% -$507K
BFLY.WS
46
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$140K ﹤0.01%
1,713,333
BHC icon
47
Bausch Health
BHC
$2.21B
-1,307,068
Closed -$9.11M
CNC icon
48
Centene
CNC
$31.7B
-1,431,312
Closed -$94.9M
CRS icon
49
Carpenter Technology
CRS
$27.7B
-130,000
Closed -$14.2M
ELV icon
50
Elevance Health
ELV
$84.9B
-98,578
Closed -$53.4M

Similar funds

Glenview Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Glenview Capital Management held 55 positions worth $5.17B, up 1.7% from $5.08B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Glenview Capital Management withdrew a net $368M in Q3 2024, closing 9 positions and reducing 19 holdings. Its most notable exit was Centene, an estimated $94.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 52% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Seagate worth $44.1M.

  • Glenview Capital Management's largest Q3 2024 buy was Seagate: 402,771 shares worth $44.1M.
  • Glenview Capital Management added most to CVS Health in Q3 2024, an estimated $162M increase.
  • Glenview Capital Management's biggest Q3 2024 reduction was Tenet Healthcare, cutting an estimated $304M.
  • Glenview Capital Management fully exited Centene in Q3 2024, selling an estimated $94.9M.
  • Glenview Capital Management's ten largest holdings make up 64% of its $5.17B portfolio in Q3 2024.
  • Glenview Capital Management opened 7 new positions and closed 9 in Q3 2024.
  • Glenview Capital Management's portfolio value rose 1.7% quarter-over-quarter to $5.17B.

Based on Glenview Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.